Cravath, Swaine & Moore announced that Daniel K. Zach, a leading antitrust lawyer and former Assistant Director, Federal Trade Commission (FTC), has joined the Firm as a partner.
Mr. Zach will advise clients on a wide range of antitrust issues, including mergers, business practices, and litigation.
“Dan’s experience as first-chair litigator trying groundbreaking merger cases, along with the successful relationships he has built with antitrust enforcers around the world, will enhance Cravath’s ability to advise our clients in navigating today’s dynamic antitrust environment,” said Faiza J. Saeed, Cravath’s Presiding Partner. “We are delighted to welcome him to the Firm.”
Mr. Zach served as Assistant Director of the FTC’s Mergers I Division, which oversees the health care sector, including merger review in pharmaceuticals, life sciences, medical devices and technology. He was responsible for managing all aspects of the division’s antitrust merger investigations. He earned multiple awards while at the FTC, including the Commission’s Excellence in Supervision Award, the Bureau of Competition Director’s Award, and the Janet D. Steiger team awards for several cases.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition – Year of the Dragon
Apr 16, 2024 by
CPI
Review Logic and Rules for Concentrations of Undertakings that Do Not Meet the Standard of Notification
Apr 16, 2024 by
CPI
China’s Review of Semiconductor Transactions
Apr 16, 2024 by
CPI
Key Challenges and Tips for Merger Control Filing in China for Listed Companies
Apr 16, 2024 by
CPI
Key Point Review: China SPC Antitrust Judgments in 2023
Apr 16, 2024 by
CPI